Sumitomo Mitsui DS Asset Management Company Ltd Grows Position in Intuitive Surgical, Inc. $ISRG

Posted by Brian Himes on May 6th, 2026

Sumitomo Mitsui DS Asset Management Company Ltd raised its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report) by 1.8% during the fourth quarter, according to its most recent filing with the SEC. The firm owned 71,874 shares of the medical equipment provider’s stock after purchasing an additional 1,299 shares during the period. Sumitomo Mitsui DS Asset Management Company Ltd’s holdings in Intuitive Surgical were worth $40,707,000 at the end of the most recent reporting period.

Other hedge funds have also recently modified their holdings of the company. Riversedge Advisors LLC lifted its holdings in Intuitive Surgical by 1.9% during the fourth quarter. Riversedge Advisors LLC now owns 901 shares of the medical equipment provider’s stock worth $510,000 after buying an additional 17 shares during the period. Fiduciary Financial Group LLC boosted its position in Intuitive Surgical by 2.1% during the fourth quarter. Fiduciary Financial Group LLC now owns 920 shares of the medical equipment provider’s stock valued at $521,000 after purchasing an additional 19 shares in the last quarter. Prosperity Consulting Group LLC raised its holdings in Intuitive Surgical by 0.5% in the third quarter. Prosperity Consulting Group LLC now owns 4,033 shares of the medical equipment provider’s stock worth $1,804,000 after purchasing an additional 19 shares in the last quarter. Rossmore Private Capital boosted its holdings in shares of Intuitive Surgical by 2.0% in the 3rd quarter. Rossmore Private Capital now owns 998 shares of the medical equipment provider’s stock valued at $446,000 after buying an additional 20 shares in the last quarter. Finally, Activest Wealth Management grew its position in shares of Intuitive Surgical by 21.7% in the 3rd quarter. Activest Wealth Management now owns 112 shares of the medical equipment provider’s stock worth $50,000 after buying an additional 20 shares during the last quarter. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Analysts Set New Price Targets

Several brokerages have weighed in on ISRG. Evercore lowered their target price on shares of Intuitive Surgical from $550.00 to $480.00 and set a “neutral” rating for the company in a research note on Monday, April 6th. BTIG Research restated a “buy” rating and set a $574.00 target price on shares of Intuitive Surgical in a research note on Wednesday, April 22nd. Sanford C. Bernstein upped their target price on Intuitive Surgical from $740.00 to $750.00 and gave the company an “outperform” rating in a research report on Friday, January 23rd. Citigroup upgraded shares of Intuitive Surgical from a “neutral” rating to a “buy” rating and set a $590.00 price objective on the stock in a report on Wednesday, March 11th. Finally, The Goldman Sachs Group lifted their price objective on shares of Intuitive Surgical from $609.00 to $621.00 and gave the stock a “buy” rating in a research note on Wednesday, April 22nd. Eighteen research analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $581.91.

Get Our Latest Stock Report on ISRG

Intuitive Surgical Price Performance

Shares of Intuitive Surgical stock opened at $451.38 on Wednesday. The stock has a market cap of $159.86 billion, a PE ratio of 54.71, a price-to-earnings-growth ratio of 3.61 and a beta of 1.51. The firm has a fifty day moving average price of $473.81 and a 200 day moving average price of $517.22. Intuitive Surgical, Inc. has a 1 year low of $427.84 and a 1 year high of $603.88.

Intuitive Surgical (NASDAQ:ISRG – Get Free Report) last announced its quarterly earnings results on Tuesday, April 21st. The medical equipment provider reported $2.50 earnings per share for the quarter, topping the consensus estimate of $2.08 by $0.42. Intuitive Surgical had a return on equity of 15.98% and a net margin of 28.15%.The company had revenue of $2.77 billion for the quarter, compared to the consensus estimate of $2.62 billion. During the same period last year, the firm earned $1.81 EPS. The firm’s revenue for the quarter was up 23.0% compared to the same quarter last year. As a group, equities analysts expect that Intuitive Surgical, Inc. will post 8.57 EPS for the current year.

Insiders Place Their Bets

In other news, VP Fredrik Widman sold 133 shares of Intuitive Surgical stock in a transaction that occurred on Wednesday, February 11th. The shares were sold at an average price of $494.96, for a total transaction of $65,829.68. Following the completion of the transaction, the vice president directly owned 660 shares of the company’s stock, valued at $326,673.60. The trade was a 16.77% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, EVP Myriam Curet sold 105 shares of Intuitive Surgical stock in a transaction on Tuesday, March 10th. The shares were sold at an average price of $493.95, for a total transaction of $51,864.75. The SEC filing for this sale provides additional information. In the last quarter, insiders have sold 5,906 shares of company stock worth $2,907,726. Corporate insiders own 0.60% of the company’s stock.

Intuitive Surgical Profile

(Free Report)

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.